HomeInsightsStock Comparison

Gennex Laboratories Ltd vs Kilitch Drugs India Ltd Stock Comparison

Gennex Laboratories Ltd vs Kilitch Drugs India Ltd Stock Comparison

Last Updated on: Aug 03, 2025

Key Highlights

  • The Latest Trading Price of Gennex Laboratories Ltd is ₹ 12.59 as of 01 Aug 15:30.
  • The P/E Ratio of Gennex Laboratories Ltd changed from 12.4 on March 2020 to 27.2 on March 2024 . This represents a CAGR of 17.01% over 5 yearsThe P/E Ratio of Kilitch Drugs (India) Ltd changed from 147.7 on March 2020 to 42.9 on March 2024 . This represents a CAGR of -21.91% over 5 years.
  • The Market Cap of Gennex Laboratories Ltd changed from ₹ 23.53 crore on March 2020 to ₹ 359.37 crore on March 2024 . This represents a CAGR of 72.50% over 5 yearsThe Market Cap of Kilitch Drugs (India) Ltd changed from ₹ 125.4 crore on March 2020 to ₹ 626.97 crore on March 2024 . This represents a CAGR of 37.97% over 5 years.
  • The revenue of Gennex Laboratories Ltd for the Mar '25 is ₹ 44.16 crore as compare to the Dec '24 revenue of ₹ 40.01 crore. This represent the growth of 10.37% The revenue of Kilitch Drugs (India) Ltd for the Mar '25 is ₹ 62.92 crore as compare to the Dec '24 revenue of ₹ 57.89 crore. This represent the growth of 8.69%.
  • The ebitda of Gennex Laboratories Ltd for the Mar '25 is ₹ 5.85 crore as compare to the Dec '24 ebitda of ₹ 7.15 crore. This represent the decline of -18.18% The ebitda of Kilitch Drugs (India) Ltd for the Mar '25 is ₹ 16.29 crore as compare to the Dec '24 ebitda of ₹ 10.46 crore. This represent the growth of 55.74%.
  • The net profit of Gennex Laboratories Ltd changed from ₹ 2.85 crore to ₹ 3.07 crore over 8 quarters. This represents a CAGR of 3.79% The net profit of Kilitch Drugs (India) Ltd changed from ₹ 3.06 crore to ₹ 10.22 crore over 8 quarters. This represents a CAGR of 82.75% .
  • The Dividend Payout of Gennex Laboratories Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Kilitch Drugs (India) Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Gennex Laboratories Ltd

  • Gennex Laboratories Limited (formerly Prudential Pharmaceuticals Limited) was incorporated on June 25, 1985.
  • The Company got converted into a Public Limited Company and the name was changed from Prudential Pharmaceuticals Limited to Gennex Laboratories Limited in 2007. The Company is one of the leading manufacturers and exporters of Active pharmaceutical ingredients and Intermediates.
  • It is engaged in manufacturing and marketing of bulk drugs and intermediates. Gennex is among the leading Vertically Integrated' pharmaceutical companies in India and has a robust product portfolio spread over major product segments encompassing Expectorants, Muscle Relaxants, Analgesic and Anti Fungal.
  • The company thrives on the strength of its exports to various countries viz.
  • Germany, United Kingdom, Spain, Singapore, Canada, Switzerland, Iran, Bangladesh, Pakistan and Others.

About Kilitch Drugs (India) Ltd

  • Kilitch Drugs (India) Limited (KDIL), incorporated in May, 1992 is the one of the leading and fastest growing pharmaceutical companies in the world, manufacturing, supplying and marketing broad range of pharmaceutical formulations in the various dosage forms like Solid, Liquid and Parental across the globe.
  • Their extensive research efforts have led to development of comprehensive, diverse and highly complementary portfolio of medicines targeting a wide spectrum of chronic and acute treatments which includes Sterile dosages namely Injectables & Ophthalmic, Effervescent tablets & Granules, Tablets & Capsules, OTC range covering varied Nutraceuticals & Cosmetics and Medical devices. The Company is engaged in development, manufacturing and marketing of quality finished dosages.
  • The Company is one of the most reliable manufacturer of injectables in India and one of the largest manufacturer of cephalosporins in Africa having its manufacturing unit located in India and Ethiopia.

Gennex Laboratories Ltd News Hub

News

Gennex Laboratories to declare Quarterly Results

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 14 Aug...

Read more

29 Jul 2025 11:10

News

Gennex Laboratories to discuss results

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 30 May...

Read more

21 May 2025 18:32

News

Gennex Laboratories to hold board meeting

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 14 Feb...

Read more

04 Feb 2025 10:33

News

Gennex Laboratories schedules board meeting

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 14 Nov...

Read more

07 Nov 2024 14:11

News

Gennex Laboratories AGM scheduled

Gennex Laboratories announced that the 39th Annual General Meeting (AGM) of the company wi...

Read more

11 Sep 2024 17:20

News

Gennex Laboratories to hold board meeting

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 6 Sept...

Read more

28 Aug 2024 15:49

Kilitch Drugs (India) Ltd News Hub

News

Kilitch Drugs (India) to convene board meeting

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 2 Ju...

Read more

30 Jun 2025 10:20

News

Kilitch Drugs (India) to convene board meeting

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 19 M...

Read more

14 May 2025 11:58

News

Kilitch Drugs (India) to convene board meeting

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 11 F...

Read more

04 Feb 2025 15:55

News

Kilitch Drugs (India) announces board meeting date

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 12 N...

Read more

05 Nov 2024 13:41

News

Kilitch Drugs (India) to convene AGM

Kilitch Drugs (India) announced that the 32th Annual General Meeting (AGM) of the company ...

Read more

31 Aug 2024 15:38

News

Kilitch Drugs (India) to conduct board meeting

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 8 Au...

Read more

02 Aug 2024 17:27

SWOT Analysis Of Gennex Laboratories Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Kilitch Drugs (India) Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Gennex Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Kilitch Drugs (India) Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Gennex Laboratories Ltd and Kilitch Drugs (India) Ltd

Which company has a larger market capitalization, Gennex Laboratories Ltd or Kilitch Drugs (India) Ltd?

Market cap of Gennex Laboratories Ltd is 286 Cr while Market cap of Kilitch Drugs (India) Ltd is 777 Cr

What are the key factors driving the stock performance of Gennex Laboratories Ltd and Kilitch Drugs (India) Ltd?

The stock performance of Gennex Laboratories Ltd and Kilitch Drugs (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gennex Laboratories Ltd and Kilitch Drugs (India) Ltd?

As of August 3, 2025, the Gennex Laboratories Ltd stock price is INR ₹12.59. On the other hand, Kilitch Drugs (India) Ltd stock price is INR ₹445.0.

How do dividend payouts of Gennex Laboratories Ltd and Kilitch Drugs (India) Ltd compare?

To compare the dividend payouts of Gennex Laboratories Ltd and Kilitch Drugs (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions